Literature DB >> 9353600

Multicenter evaluation of the Micral-Test II test strip, an immunologic rapid test for the detection of microalbuminuria.

C E Mogensen1, G C Viberti, E Peheim, D Kutter, C Hasslacher, W Hofmann, R Renner, M Bojestig, P L Poulsen, G Scott, J Thoma, J Kuefer, B Nilsson, B Gambke, P Mueller, J Steinbiss, K D Willamowski.   

Abstract

OBJECTIVE: To assess the performance of the Micral-Test II immunologic test strip for the detection of microalbuminuria, a multicenter evaluation in eight European study sites was performed. RESEARCH DESIGN AND METHODS: Using both the Micral-Test II test strip and the routine method for the determination of albumin concentration, we investigated 2,228 urine samples from diabetic patients. Additionally, interperson variability, color stability, and possible interfering factors (temperature, pH, leucocyturia, erythrocyturia, and drugs) were tested.
RESULTS: For a cutoff concentration of 20 mg/l with respect to the routine methods, a sensitivity of 96.7% and a specificity of 71% were calculated for the Micral-Test II test strip. The negative predictive value was 0.95, and the positive predictive value was 0.78, with a prevalence of positive samples (laboratory method) of 52%. The interperson variability of color interpretation showed 93% concordant readings. The interference study showed an influence of oxytetracycline, leading to higher readings. There was no interference from pH. A sample temperature of < 10 degrees C led to lower readings. In the case of samples with massive leucocyturia and erythrocyturia that may delete the chromatographic process, waiting an additional 1-2 min is needed before reading.
CONCLUSIONS: The results of the multicenter evaluation show that the Micral-Test II test strip permits an immediate and reliable semiquantitative determination of low albumin concentrations in urine samples with an almost user-independent color interpretation.

Entities:  

Mesh:

Year:  1997        PMID: 9353600     DOI: 10.2337/diacare.20.11.1642

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  7 in total

Review 1.  Urinary strips for protein assays: easy to do but difficult to interpret!

Authors:  Guillaume Résimont; Laurence Piéroni; Edith Bigot-Corbel; Etienne Cavalier; Pierre Delanaye
Journal:  J Nephrol       Date:  2020-04-23       Impact factor: 3.902

2.  Renal and cardiovascular risk predictive value of two different microalbuminuria screening methods in patients with hypertension with/without diabetes in Portugal.

Authors:  J Polónia; D Carvalho; J Nazaré; L Martins; P M da Silva; C Aguiar; M C Manso; T Carqueja
Journal:  J Hum Hypertens       Date:  2016-01-07       Impact factor: 3.012

Review 3.  Cost-effective strategies in the prevention of diabetic nephropathy.

Authors:  Jonathan D Rippin; Anthony H Barnett; Stephen C Bain
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

4.  Screening for Nephropathy in Diabetes Mellitus: Is Micral-Test Valid among All Diabetics?

Authors:  Koubaa Afifa; Sriha Belguith Asma; Harzallah Nabil; Bellaleh Ahlem; Sahtout Mounira; Younes Kawthar; Triki Sonia; Hellara Ilhem; Neffati Fadoua; Najjar Fadhel; Soltani Mohamed
Journal:  Int J Chronic Dis       Date:  2016-05-18

5.  The Effectiveness of the Semi-quantitative Assessment of Microalbuminuria Using Routine Urine Dipstick Screening in Patients with Diabetes.

Authors:  Tsuguka Shiwa; Maho Nishimura; Masaya Kato
Journal:  Intern Med       Date:  2017-12-21       Impact factor: 1.271

Review 6.  Comparison of commonly used assays for the detection of microalbuminuria.

Authors:  Douglas E Busby; George L Bakris
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-11       Impact factor: 3.738

7.  Prevalence and determinants of microalbuminuria among diabetic patients in the United Arab Emirates.

Authors:  Fatma Al-Maskari; Mohammed El-Sadig; Enyioma Obineche
Journal:  BMC Nephrol       Date:  2008-01-29       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.